abstract |
(57) [Summary]nProvided are novel fibrinogen receptor antagonists of the formula: XYZ- "aryl" -A-B, which exhibit fibrinogen receptor antagonist activity and are useful in inhibiting platelet aggregation and thus mitigating thrombus formation. |